カテゴリー： QYResearch, 世界

世界の遺伝子ワクチン産業：成長傾向・競合分析2019-2025

【英語タイトル】Global Genetic Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料（DATA909X01016）・商品コード：DATA909X01016
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートでは、世界の遺伝子ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。遺伝子ワクチンの種類別には、組換えタンパク質ワクチン、遺伝子ベースワクチンに、用途別には、人間、動物に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・遺伝子ワクチンの種類別市場規模：組換えタンパク質ワクチン、遺伝子ベースワクチン
・遺伝子ワクチンの用途別市場規模：人間、動物
・遺伝子ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.In 2018, the global Genetic Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Genetic Vaccine.

This study researches the market size of Genetic Vaccine, presents the global Genetic Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Genetic Vaccine in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Genetic Vaccine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

Market Segment by Product Type
Recombinant Protein Vaccine
Gene-Based Vaccine

Market Segment by Application
Human
Animal

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Genetic Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Genetic Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Genetic Vaccine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Genetic Vaccine Market Size Growth Rate by Type
1.3.2 Recombinant Protein Vaccine
1.3.3 Gene-Based Vaccine
1.4 Market Segment by Application
1.4.1 Global Genetic Vaccine Market Share by Application (2019-2025)
1.4.2 Human
1.4.3 Animal
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Genetic Vaccine Market Size
2.1.1 Global Genetic Vaccine Revenue 2014-2025
2.1.2 Global Genetic Vaccine Sales 2014-2025
2.2 Genetic Vaccine Growth Rate by Regions
2.2.1 Global Genetic Vaccine Sales by Regions 2014-2019
2.2.2 Global Genetic Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Genetic Vaccine Sales by Manufacturers
3.1.1 Genetic Vaccine Sales by Manufacturers 2014-2019
3.1.2 Genetic Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Genetic Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Genetic Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Genetic Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Genetic Vaccine Price by Manufacturers
3.4 Key Manufacturers Genetic Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Genetic Vaccine Market
3.6 Key Manufacturers Genetic Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Recombinant Protein Vaccine Sales and Revenue (2014-2019)
4.1.2 Gene-Based Vaccine Sales and Revenue (2014-2019)
4.2 Global Genetic Vaccine Sales Market Share by Type
4.3 Global Genetic Vaccine Revenue Market Share by Type
4.4 Genetic Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Genetic Vaccine Sales by Application

6 North America
6.1 North America Genetic Vaccine Breakdown Data by Company
6.2 North America Genetic Vaccine Breakdown Data by Type
6.3 North America Genetic Vaccine Breakdown Data by Application
6.4 North America Genetic Vaccine Breakdown Data by Countries
6.4.1 North America Genetic Vaccine Sales by Countries
6.4.2 North America Genetic Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Genetic Vaccine Breakdown Data by Company
7.2 Europe Genetic Vaccine Breakdown Data by Type
7.3 Europe Genetic Vaccine Breakdown Data by Application
7.4 Europe Genetic Vaccine Breakdown Data by Countries
7.4.1 Europe Genetic Vaccine Sales by Countries
7.4.2 Europe Genetic Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Genetic Vaccine Breakdown Data by Company
8.2 Asia Pacific Genetic Vaccine Breakdown Data by Type
8.3 Asia Pacific Genetic Vaccine Breakdown Data by Application
8.4 Asia Pacific Genetic Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Genetic Vaccine Sales by Countries
8.4.2 Asia Pacific Genetic Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Genetic Vaccine Breakdown Data by Company
9.2 Central & South America Genetic Vaccine Breakdown Data by Type
9.3 Central & South America Genetic Vaccine Breakdown Data by Application
9.4 Central & South America Genetic Vaccine Breakdown Data by Countries
9.4.1 Central & South America Genetic Vaccine Sales by Countries
9.4.2 Central & South America Genetic Vaccine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Genetic Vaccine Breakdown Data by Type
10.2 Middle East and Africa Genetic Vaccine Breakdown Data by Application
10.3 Middle East and Africa Genetic Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Genetic Vaccine Sales by Countries
10.3.2 Middle East and Africa Genetic Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Genetic Vaccine
11.1.4 Genetic Vaccine Product Introduction
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Genetic Vaccine
11.2.4 Genetic Vaccine Product Introduction
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Genetic Vaccine
11.3.4 Genetic Vaccine Product Introduction
11.3.5 Sanofi Recent Development
11.4 Zoties
11.4.1 Zoties Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Genetic Vaccine
11.4.4 Genetic Vaccine Product Introduction
11.4.5 Zoties Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Genetic Vaccine
11.5.4 Genetic Vaccine Product Introduction
11.5.5 Elanco Recent Development
11.6 Boehringer-Ingelheim
11.6.1 Boehringer-Ingelheim Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Genetic Vaccine
11.6.4 Genetic Vaccine Product Introduction
11.6.5 Boehringer-Ingelheim Recent Development
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Genetic Vaccine
11.7.4 Genetic Vaccine Product Introduction
11.7.5 Indian Immunologicals Recent Development
11.8 Plumbline Life Sciences
11.8.1 Plumbline Life Sciences Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Genetic Vaccine
11.8.4 Genetic Vaccine Product Introduction
11.8.5 Plumbline Life Sciences Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Genetic Vaccine Sales Channels
12.2.2 Genetic Vaccine Distributors
12.3 Genetic Vaccine Customers

13 Market Forecast
13.1 Global Genetic Vaccine Sales and Revenue Forecast 2019-2025
13.2 Global Genetic Vaccine Sales Forecast by Type
13.3 Global Genetic Vaccine Sales Forecast by Application
13.4 Genetic Vaccine Forecast by Regions
13.4.1 Global Genetic Vaccine Sales Forecast by Regions 2019-2025
13.4.2 Global Genetic Vaccine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Genetic Vaccine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Genetic Vaccine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Genetic Vaccine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Genetic Vaccine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Genetic Vaccine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Genetic Vaccine Product Picture
Table Genetic Vaccine Key Market Segments
Table Major Manufacturers Genetic Vaccine Covered in This Report
Table Global Genetic Vaccine Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Genetic Vaccine Sales Market Shar by Type 2014-2025
Figure Recombinant Protein Vaccine Figures
Table Major Manufacturers of Recombinant Protein Vaccine
Figure Gene-Based Vaccine Figures
Table Major Manufacturers of Gene-Based Vaccine
Table Global Genetic Vaccine Market Share by Application 2019-2025 (K Units)
Figure Human Use Case
Figure Animal Use Case
Figure Genetic Vaccine Report Years Considered
Figure Global Genetic Vaccine Market Size 2014-2025 (Million US$)
Figure Global Genetic Vaccine Sales 2014-2019 (K Units)
Table Global Genetic Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Genetic Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Genetic Vaccine Sales Market Share by Regions 2014-2019
Figure Global Genetic Vaccine Sales Market Share by Regions 2014-2019
Figure Global Genetic Vaccine Sales Market Share by Regions in 2018
Table Global Genetic Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Genetic Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Genetic Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Genetic Vaccine Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Genetic Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Genetic Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Genetic Vaccine Sales Share by Manufacturers in 2018
Table Genetic Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Genetic Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Genetic Vaccine Value Share by Manufacturers in 2018
Table Global Genetic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Genetic Vaccine Price (2014-2019) (USD/Unit)
Table Key Manufacturers Genetic Vaccine Plants/Factories Distribution
Table Key Manufacturers Genetic Vaccine Area Served
Table Date of Key Manufacturers Enter into Genetic Vaccine Market
Table Key Manufacturers Genetic Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Protein Vaccine Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Gene-Based Vaccine Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Genetic Vaccine Sales by Type (2014-2019) (K Units)
Table Global Genetic Vaccine Sales Share by Type (2014-2019)
Figure Global Genetic Vaccine Sales Market Share by Type (2014-2019)
Figure Global Genetic Vaccine Sales Market Share by Type in 2018
Table Global Genetic Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Genetic Vaccine Revenue Share by Type (2014-2019)
Figure Global Genetic Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Genetic Vaccine Revenue Market Share by Type in 2018
Table Genetic Vaccine Price by Type 2014-2019 (USD/Unit)
Table Global Genetic Vaccine Sales by Application (2014-2019) (K Units)
Table Global Genetic Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Genetic Vaccine Market Share by Application (2014-2019)
Figure Global Sales Genetic Vaccine Market Share by Application in 2018
Figure North America Genetic Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Genetic Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Genetic Vaccine Sales by Company (2014-2019) (K Units)
Table North America Genetic Vaccine Sales Market Share by Company (2014-2019)
Figure North America Genetic Vaccine Sales Market Share by Company in 2018
Table North America Genetic Vaccine Sales by Type (2014-2019) (K Units)
Table North America Genetic Vaccine Sales Market Share by Type (2014-2019)
Figure North America Genetic Vaccine Market Share by Type in 2018
Table North America Genetic Vaccine Sales by Application (2014-2019) (K Units)
Table North America Genetic Vaccine Sales Market Share by Application (2014-2019)
Figure North America Genetic Vaccine Market Share by Application in 2018
Table North America Genetic Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Genetic Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Genetic Vaccine Sales Market Share by Countries in 2018
Table North America Genetic Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Genetic Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Genetic Vaccine Revenue Market Share by Countries in 2018
Figure United States Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Europe Genetic Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Genetic Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Genetic Vaccine Sales by Company (2014-2019) (K Units)
Table Europe Genetic Vaccine Sales Market Share by Company (2014-2019)
Figure Europe Genetic Vaccine Sales Market Share by Company in 2018
Table Europe Genetic Vaccine Sales by Type (2014-2019) (K Units)
Table Europe Genetic Vaccine Sales Market Share by Type (2014-2019)
Figure Europe Genetic Vaccine Sales Market Share by Type in 2018
Table Europe Genetic Vaccine Sales by Application (2014-2019) (K Units)
Table Europe Genetic Vaccine Sales Market Share by Application (2014-2019)
Figure Europe Genetic Vaccine Sales Market Share by Application in 2018
Table Europe Genetic Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Genetic Vaccine Sales Market Share by Countries (2014-2019)
Figure Europe Genetic Vaccine Sales Market Share by Countries in 2018
Table Europe Genetic Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Genetic Vaccine Revenue Market Share by Countries (2014-2019)
Figure Europe Genetic Vaccine Revenue Market Share by Countries in 2018
Figure Germany Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Genetic Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Genetic Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Genetic Vaccine Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Genetic Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Genetic Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Genetic Vaccine Sales by Type (2014-2019) (K Units)
Table Asia Pacific Genetic Vaccine Sales Market Share by Type (2014-2019)
Figure Asia Pacific Genetic Vaccine Market Share by Type in 2018
Table Asia Pacific Genetic Vaccine Sales by Application (2014-2019) (K Units)
Table Asia Pacific Genetic Vaccine Sales Market Share by Application (2014-2019)
Figure Asia Pacific Genetic Vaccine Market Share by Application in 2018
Table Asia Pacific Genetic Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Genetic Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Genetic Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Genetic Vaccine Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Genetic Vaccine Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Genetic Vaccine Revenue Market Share by Regions in 2018
Figure China Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Genetic Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Genetic Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Genetic Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Genetic Vaccine Sales by Company (2014-2019) (K Units)
Table Central & South America Genetic Vaccine Sales Market Share by Company (2014-2019)
Figure Central & South America Genetic Vaccine Sales Market Share by Company in 2018
Table Central & South America Genetic Vaccine Sales by Type (2014-2019) (K Units)
Table Central & South America Genetic Vaccine Sales Market Share by Type (2014-2019)
Figure Central & South America Genetic Vaccine Market Share by Type in 2018
Table Central & South America Genetic Vaccine Sales by Application (2014-2019) (K Units)
Table Central & South America Genetic Vaccine Sales Market Share by Application (2014-2019)
Figure Central & South America Genetic Vaccine Market Share by Application in 2018
Table Central & South America Genetic Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Genetic Vaccine Sales Market Share by Countries (2014-2019)
Figure Central & South America Genetic Vaccine Sales Market Share by Countries in 2018
Table Central & South America Genetic Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Genetic Vaccine Revenue Market Share by Countries (2014-2019)
Figure Central & South America Genetic Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Genetic Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Genetic Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Genetic Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Genetic Vaccine Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Genetic Vaccine Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Genetic Vaccine Sales Market Share by Type in 2018
Table Middle East and Africa Genetic Vaccine Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Genetic Vaccine Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Genetic Vaccine Sales Market Share by Application in 2018
Table Middle East and Africa Genetic Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Genetic Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Genetic Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Genetic Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Genetic Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Genetic Vaccine Revenue Market Share by Countries in 2018
Figure GCC Countries Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Genetic Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Genetic Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Genetic Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Genetic Vaccine Revenue Growth Rate (2014-2019) (K Units)
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Genetic Vaccine Sales Growth Rate (2014-2019)
Table Merck Genetic Vaccine Sales Market Share in Global Market
Table Merck Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Genetic Vaccine Sales Growth Rate (2014-2019)
Table GSK Genetic Vaccine Sales Market Share in Global Market
Table GSK Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Genetic Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Genetic Vaccine Sales Market Share in Global Market
Table Sanofi Recent Development
Table Zoties Company Details
Table Zoties Description and Business Overview
Table Zoties Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zoties Genetic Vaccine Sales Growth Rate (2014-2019)
Table Zoties Genetic Vaccine Sales Market Share in Global Market
Table Zoties Recent Development
Table Elanco Company Details
Table Elanco Description and Business Overview
Table Elanco Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Elanco Genetic Vaccine Sales Growth Rate (2014-2019)
Table Elanco Genetic Vaccine Sales Market Share in Global Market
Table Elanco Recent Development
Table Boehringer-Ingelheim Company Details
Table Boehringer-Ingelheim Description and Business Overview
Table Boehringer-Ingelheim Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer-Ingelheim Genetic Vaccine Sales Growth Rate (2014-2019)
Table Boehringer-Ingelheim Genetic Vaccine Sales Market Share in Global Market
Table Boehringer-Ingelheim Recent Development
Table Indian Immunologicals Company Details
Table Indian Immunologicals Description and Business Overview
Table Indian Immunologicals Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Indian Immunologicals Genetic Vaccine Sales Growth Rate (2014-2019)
Table Indian Immunologicals Genetic Vaccine Sales Market Share in Global Market
Table Indian Immunologicals Recent Development
Table Plumbline Life Sciences Company Details
Table Plumbline Life Sciences Description and Business Overview
Table Plumbline Life Sciences Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Plumbline Life Sciences Genetic Vaccine Sales Growth Rate (2014-2019)
Table Plumbline Life Sciences Genetic Vaccine Sales Market Share in Global Market
Table Plumbline Life Sciences Recent Development
Figure Genetic Vaccine Value Chain
Table Genetic Vaccine Distributors List
Table Genetic Vaccine Customers List
Table Global Genetic Vaccine Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Global Genetic Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Genetic Vaccine Sales Forecast by Type 2019-2025 (K Units)
Figure Global Genetic Vaccine Sales Forecast by Type 2019-2025 (K Units)
Figure Global Genetic Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Genetic Vaccine Sales Forecast by Application 2019-2025 (K Units)
Figure Global Genetic Vaccine Sales Forecast by Application 2019-2025 (K Units)
Figure Global Genetic Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Genetic Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Genetic Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Genetic Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Genetic Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Genetic Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Genetic Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table North America Genetic Vaccine Sales Forecast by Countries 2019-2025 (K Units)
Table North America Genetic Vaccine Sales Market Share Forecast by Countries 2019-2025
Table North America Genetic Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Genetic Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure United States Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Canada Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Mexico Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Table Europe Genetic Vaccine Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Genetic Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Europe Genetic Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Genetic Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure France Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure UK Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Italy Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Russia Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Genetic Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Genetic Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Genetic Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Genetic Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure China Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Japan Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure South Korea Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure India Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Australia Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Indonesia Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Thailand Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Malaysia Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Philippines Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Vietnam Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Table Central & South America Genetic Vaccine Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Genetic Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Genetic Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Genetic Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Genetic Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Genetic Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Genetic Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Genetic Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure GCC Countries Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure Egypt Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Figure South Africa Genetic Vaccine Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences

★調査レポート[世界の遺伝子ワクチン産業：成長傾向・競合分析2019-2025] (コード：DATA909X01016)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の遺伝子ワクチン産業：成長傾向・競合分析2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の魚ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X00898 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の魚ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。魚ワクチンの種類別には、不活化魚ワクチン、弱毒魚ワクチン、トキソイド魚ワクチン、複合魚ワクチン、その他に、用途別には、獣医薬局、獣医クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・魚ワクチンの種類別市場規模：不活化魚ワクチン、弱毒魚ワクチン、トキソイド魚ワクチン、複合魚ワクチン、その他 ・魚ワクチンの用途別市場規模：獣医薬局、獣医クリニック、その他 ・魚ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Lumic A/S、Syndel USA、PHARMAQ、CZ...Vaccination plays a vital role in large scale fish farming production. Vaccination of fish provides protection against common viral or bacterial diseases. Fish vaccines can radially reduce the mortality rate and increase the production rate. Fish vaccines is the best method to enhance the survival rate and increase the profitability of the aquaculture business. Fish vaccines is generally given to species such as Salmon, Sea Bass and Cod. Fish vaccines is widely used method in aquaculture.In 2018, the global Fish Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR...
  • 世界の四価インフルエンザワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01920 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の四価インフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。四価インフルエンザワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、診療所、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・四価インフルエンザワクチンの種類別市場規模：筋肉内注射、点鼻薬、皮内注射 ・四価インフルエンザワクチンの用途別市場規模：病院、診療所、公衆衛生局、その他 ・四価インフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline ・市場規模予測2019-2025：生産量...In 2018, the global Quadrivalent Flu Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Quadrivalent Flu Vaccine. This study researches the market size of Quadrivalent Flu Vaccine, presents the global Quadrivalent Flu Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report focuses on the key...
  • 世界の三価インフルエンザワクチン産業：成長傾向・競合分析2019-2025
    DATA909X02458 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の三価インフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。三価インフルエンザワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、クリニック、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・三価インフルエンザワクチンの種類別市場規模：筋肉内注射、点鼻薬、皮内注射 ・三価インフルエンザワクチンの用途別市場規模：病院、クリニック、公衆衛生局、その他 ・三価インフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline、Serum Institute...In 2018, the global Trivalent Flu Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Trivalent Flu Vaccine. This study researches the market size of Trivalent Flu Vaccine, presents the global Trivalent Flu Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report focuses on the key...
  • 世界の動物用生物学的ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X00116 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の動物用生物学的ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。動物用生物学的ワクチンの種類別には、経口、皮下、筋肉内、その他に、用途別には、ブタ、家禽、家畜、愛玩動物、養殖に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・動物用生物学的ワクチンの種類別市場規模：経口、皮下、筋肉内、その他 ・動物用生物学的ワクチンの用途別市場規模：ブタ、家禽、家畜、愛玩動物、養殖 ・動物用生物学的ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Merck、Zoetis、Merial/Sanofi、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco/Eli...In 2018, the global Animal Biological Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Biological Vaccine. This study researches the market size of Animal Biological Vaccine, presents the global Animal Biological Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report focuses on the key...
  • 世界の組換えタンパク質ワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01954 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の組換えタンパク質ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えタンパク質ワクチンの種類別には、細菌細胞培養、哺乳類細胞培養に、用途別には、人間、動物に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・組換えタンパク質ワクチンの種類別市場規模：細菌細胞培養、哺乳類細胞培養 ・組換えタンパク質ワクチンの用途別市場規模：人間、動物 ・組換えタンパク質ワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life...Recombinant Protein Vaccine refers to the vaccines manufactured using recombinant DNA technologyIn 2018, the global Recombinant Protein Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Recombinant Protein Vaccine. This study researches the market size of Recombinant Protein Vaccine, presents the global Recombinant Protein Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to...
  • 世界の鼻スプレーイ型ンフルエンザワクチン産業：成長傾向・競合分析2019-2025
    DATA909X01574 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の鼻スプレーイ型ンフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。鼻スプレーイ型ンフルエンザワクチンの種類別には、三価インフルエンザワクチン、四価インフルエンザワクチに、用途別には、病院、クリニック、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・鼻スプレーイ型ンフルエンザワクチンの種類別市場規模：三価インフルエンザワクチン、四価インフルエンザワクチ ・鼻スプレーイ型ンフルエンザワクチンの用途別市場規模：病院、クリニック、公衆衛生局、その他 ・鼻スプレーイ型ンフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline、Serum Institute...In 2018, the global Nasal Spray Flu Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nasal Spray Flu Vaccines. This study researches the market size of Nasal Spray Flu Vaccines, presents the global Nasal Spray Flu Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025. This report...
  • 世界の次世代コンタクトレンズ及び視覚補綴産業：成長傾向・競合分析2019-2025
    DATA909X01598 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界の次世代コンタクトレンズ及び視覚補綴市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。次世代コンタクトレンズ及び視覚補綴の種類別には、治療用コンタクトレンズ、薬物溶出コンタクトレンズ、診断モニタリングコンタクトレンズ、視覚補綴に、用途別には、治療、薬物送達、診断/モニタリングに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・次世代コンタクトレンズ及び視覚補綴の種類別市場規模：治療用コンタクトレンズ、薬物溶出コンタクトレンズ、診断モニタリングコンタクトレンズ、視覚補綴 ・次世代コンタクトレンズ及び視覚補綴の用途別市場規模：治療、薬物送達、診断/モニタリング ・次世代コンタクトレンズ及び視覚補綴の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Abbott、Bionic Sight、Alden Optical、Allergan、Applied...There are several unmet needs in ophthalmology, and recent technological advances and the availability of new biomaterials have greatly expanded the potential applications of contact lenses.Diabetes and glaucoma are key clinical conditions for developing contact lenses to evaluate and track various disease parameters.The next generation of contact lenses and visual prosthetics are used for purposes other than vision correction, such as treatment, drug delivery and diagnosis/monitoring.In 2018, the global Next Generation Contact Lenses and Visual Prostheses market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In...
  • 世界のトルテリーニ産業：成長傾向・競合分析2019-2025
    DATA909X02435 / QYResearch / 2019年11月25日 / ※本調査レポートでは、世界のトルテリーニ市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。トルテリーニの種類別には、新鮮、冷凍、乾燥、その他に、用途別には、住宅、レストラン、飛行機、電車、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・トルテリーニの種類別市場規模：新鮮、冷凍、乾燥、その他 ・トルテリーニの用途別市場規模：住宅、レストラン、飛行機、電車、その他 ・トルテリーニの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Nestle、Giovanni Rana、Buitoni、Barilla、Rana Cheese、Ronzoni...Tortellini are ring-shaped pasta, sometimes also described as "navel shaped", hence their alternative name of "belly button". Originally from the Italian region of Emilia, they are usually stuffed with a mix of meat, Parmigiano Reggiano cheese, egg and nutmeg. They are traditionally served in capon broth.In 2018, the global Tortellini market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tortellini. This...

    • ◆H&Iグローバルリサーチのお客様（例）◆